Can it be that there’s now a blood test that can help diagnose MS? This company says it has one and doctors can order it. For a disease that’s always been difficult to diagnose, as
The life science tech company IQuity has begun taking orders from physicians for an RNA-based blood test, it reports, that can provide reliable yes or no results for multiple sclerosis in seven days — dramatically faster than previous options, which took months or years.
The test, IsolateMS, can be a game-changer in diagnosing MS when administered at the start of symptoms, the company said. Currently, diagnostics for MS rely on measuring the progress of irreversible neurological damage.
Winner of $4.9 Million Research Award Tests Online and Teleconference-based Methods to Reduce MS-related Fatigue
I could joke that I’m too tired to write about this, but fatigue is no joking matter to many of us with MS. So, the idea that someone is researching a program to reduce fatigue without a patient having to travel anywhere to be treated is something I want to learn more about. This research is just getting started, so I’ll be watching with great interest.
People with MS often face geographic barriers that end up limiting their treatment options. That has led a Case Western Reserve University researcher to test online- and teleconference-based methods of reducing fatigue and improving patients’ quality of life.
Matthew Plow, assistant professor at the university’s Frances Payne Bolton School of Nursing in Cleveland, Ohio, recently won a $4.9 million award from the Patient-Centered Outcomes Research Institute (PCORI) for his four-year project.
TG-1101 is one of the newest type of disease modifying therapies. These therapies use a monoclonal antibody that targets B-cells that carry the CD20 protein. Those are the “rogue” cells that are thought to attack the myelin of MS patients. (Ocrevus is a drug that acts similarly).
TG Therapeutics is recruiting participants for two Phase 3 clinical trials that will evaluate the safety and effectiveness of TG-1101 (ublituximab) as a treatment for relapsing forms of multiple sclerosis.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?